Patients with pelvic masses present with numerous symptoms to include: pain, bloating, pelvic pressure, changes in bowel or bladder habits, and abdominal distention. Imaging usually follows to elucidate etiology. In the United States, it is estimated that there is a 5-10% lifetime risk for women undergoing surgery for a suspected ovarian neoplasm [1]. When masses are identified, surgery is often recommended. Consent forms have become stricter as patient safety concerns for wrong site and wrong side surgeries have increased. Preoperative specified laterality with skin marking or side-banding prior to surgical invention has been recommended to potentially improve patient outcomes. The present authors undertook this study to evaluate concordance of laterality between imaging and surgical findings. Materials and Methods All 705 patients from a single practice sub-specialty provider were reviewed from January 2015 to October 2017. Admission diagnosis on 666 surgical candidates was complete, 285 patients with a diagnosis of pelvic or adnexal mass were identified, and 280 had final data for review. All patients had surgery within two weeks of subspecialty consultation. Data was abstracted and variables for review included: age, imaging study (ultrasound, CT, MRI) imaging dimensions, imaging laterality, pathologic findings to include histology, pathologic dimensions, and surgical laterality. Volume was attempted to be calculated for both imaging and pathologic data. Three-point data was not available in the majority of imaging studies and pathology reports, therefore the largest dimension recorded had to be used as the final data-point. The authors performed subset analyses of patient age, imaging modality, concordance of imaging modalities within themselves, effect of mass size, and a cancer diagnosis and compared these variables to surgical findings. Data was entered into Excel. Statistical analysis was performed using Graphpad 2018 and Socscistatistics 2018. A p value of ≤ 0.05 was considered significant. All tests were two-tailed and confidence intervals (CI) were set at 95%. IRB approval was requested from the Group Health Research Institute and it was determined that this review was exempt on June 16, 2017 as a Quality Improvement project.